USPTO serial 77585985
HSRX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- WEBSTER, WILLIAM M
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HSRX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer L. Whitelaw
JENNIFER L. WHITELAW WHITELAW LEGAL GROUP3838 TAMIAMI TRL N STE 310NAPLES, FL 34103-3586UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Botanical extracts for use in the manufacture of nutraceuticals and pharmaceuticals; botanical and herbal extracts for use in the manufacture of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; chemical extracts and active principles extracted from medicinal plants for use in the manufacture of nutraceuticals and pharmaceuticals; chemical extracts and active principles extracted from medicinal plants for use in the pharmaceutical industry, namely, chemical agents made from botanical extracts and an association of chemical extracts for use in the manufacture of pharmaceutical or nutraceutical products; botanical extracts used in the manufacture of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, algal extracts and algal extract blends, all for use in the manufacture of nutritional supplements and vitamins; herbal extracts and blends for use in manufacturing functional foods and beverages; herbal extracts and blends for use in manufacturing medicinal foods and beverages; botanical extracts and blends for use in manufacturing functional foods and beverages; botanical extracts and blends for use in manufacturing medicinal foods and beverages; herbal preparations and extracts for use as ingredients in manufacturing in the food, nutrition, nutraceutical and/or pharmaceutical industries | ACTIVE | — |
| 005 | Nutritional additives for medical and non-medical purposes for use in manufacturing foods and dietary supplements for human consumption; herbs and herbal blends for use in the manufacture of nutritional supplements and vitamins; nutritional supplements; herbal products, namely, nutritional additives for medical purposes for use in foods and dietary supplements for human consumption, medicated skin and lip balms; herbal products, namely, ointments, oils, drinks, infusions, syrups, herbal extracts, poisons, and tinctures for medical use in the treatment of strokes, infarcts and other cardiovascular and cerebrum diseases; herbal products, namely, ointments, oils, namely, mineral oil for use as a laxative; drinks, namely, meal replacement drinks, dietary supplement drinks, medicinal drinks, and fish oil for use as a dietary supplement or in a nutraceutical; infusions and syrups, namely, cough syrups; herbal products for medicinal purposes, namely, herbal extracts for use as nutritional and dietary supplements; nutritional additives for medical or nutritional purposes for use in manufacturing foods and dietary supplements for human consumption; herbal products for medicinal purposes, namely, herbal extracts and syrups; medicinal herb extracts for medical purposes; plant extracts for medical, pharmaceutical, nutraceutical and nutritional purposes; medicinal extracts used in preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; medicinal herb extracts for medical purposes in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; medicinal herbal extracts for medical purposes in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; medicinal botanical extracts in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection used to treat skin ailments, for infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related medical conditions; yeast extracts for medical, pharmaceutical or nutraceutical purposes; herbal products, namely, herbal powders for nutritional purposes; herbal products, namely, herbal meal replacement powders for dietary and nutritional purposes; herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; herbal products, namely, herbal powders sold as an integral ingredient of nutritional supplement drink mix for nutritional purposes; pharmaceuticals and nutraceuticals, namely, vitamins and food supplements; pharmaceutical preparations, namely, appetite suppressants and lipid lowering agents; food for diabetics, infants and enteral feeding; botanical extracts for nutritional use; botanical extracts for medical, veterinary, nutraceutical and pharmaceutical purposes; designer extracts, namely, herbal extracts for medical, veterinary and pharmaceutical purposes; botanical extracts for nutritional supplements, nutraceuticals and pharmaceuticals; nutritional dietary supplements; oral pharmaceutical and nutritional preparations containing herbs or herbal extracts used for the treatment of, or relief of symptoms in, infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and/or related medical conditions; vitamin and mineral preparations intended for use as dietary supplements; vitamins; food supplements; nutraceuticals, namely, vitamins and food supplements; food for medically restricted diets; supplements, namely, lipid concentrates for use as a dietary food supplement or for pharmaceutical or medicinal purposes; food supplements, namely, anti-oxidants; botanicals and botanical blends, herbal and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, all sold as components of nutritional supplements and vitamins; nutritional oils not for cosmetic purposes; anti-cough drops; cough drops; cough expectorants; throat lozenges; cough lozenges; cough syrups; cough treatment preparations; cold sore treatment preparations; pharmaceutical antitussive-cold preparations; preparations for treating colds; analgesic preparations; analgesics; antipyretic analgesics; ibuprofen for use as an oral analgesic; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; oral analgesics; topical analgesics; pharmaceutical preparations for the treatment and prevention of herpes; vaccines for the treatment and prevention herpes; biological preparations for the treatment and prevention of herpes; pharmaceutical preparations for the treatment of herpes simplex infection; pharmaceutical capsules for the treatment of herpes simplex infection; homeopathic pharmaceutical preparations for the treatment of herpes and cold sores; pharmaceutical preparations for the treatment of herpes viruses; medicated topical clear fluoride gel for the treatment of herpes virus during the physical manifestation of the virus; pharmaceutical preparations for the treatment of herpes simplex virus type I or type II or Herpes Zoster virus, not in intravenous form; plant-based antivirals; over-the-counter topical antivirals; pharmaceutical preparation with antiviral and/or antimicrobial properties for use in the treatment of herpetic keratitis, conjunctivitis, HIV retinopathy, viral influenza "flu", Herpes Simplex virus 1, Herpes Simplex virus 2, Varicella Zoster virus "herpes zoster" or "shingles", cytomegalovirus, viral parainfluenza, adenovirus, viral encephalitis, viral meningitis, arbovirus, arenavirus, picornavirus, coronavirus, syntialvirus, viral infections, common colds caused by viruses, cold sores, human immunedeficiency virus "HIV", roseola infantum, human herpes IV; pharmaceutical preparations for the treatment of viral diseases and disorders, namely, herpes; pharmaceutical preparations for treating immune diseases induced by virus, namely, herpes, herpes zoster and AIDS; algal products for medicinal purposes, namely, algal extracts and algal extract blends for use as nutritional and dietary supplements; algal products, namely, algal powders sold as an integral ingredient of nutritional supplement drink mix for nutritional purposes; algal products, namely, algal powders for nutritional purposes; algal extracts and algal extract blends for medical or pharmaceutical purposes; functional foods, namely, dietetic foods adapted for medical purposes; functional beverages, namely, nutritionally fortified beverages; medicinal foods, namely, processed food for medical purposes; animal health products, namely, animal feed supplements, medicated animal feed, micro-nutrient animal feed, dietary supplements for animals, non-medicated additives for animal feed for use as nutritional supplements, nutritional drinks for animals, pharmaceutical preparations for animal skincare; plant extracts for medical, veterinary and pharmaceutical purposes; designer extracts, namely, plant, herbal and botanical extracts for medical, veterinary and pharmaceutical purposes; and biodefense products, namely, medicinal preparations for the treatment of infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, and cancer; mushroom, fungus and spore extracts and blends for use as ingredients in nutritional supplements, nutraceuticals and pharmaceutical products; soy protein for use as a nutritional supplement | ACTIVE | — |
| 042 | Product research and development; scientific research and development; chemical analysis and research services regarding the identification of chemical components of various materials; research in the field of biodefense; and research and development in the field of biodefense | ACTIVE | — |
| 045 | Intellectual property licensing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HerbalScience Group, LLC
- Other trademarks owned by HerbalScience Group, LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named HSRX
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 1, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 31, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 27, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 4, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 2, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 30, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 10, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 10, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 9, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 25, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 4, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 4, 2009 | ALIE | ASSIGNED TO LIE | — |
| Apr 3, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 5, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 10, 2008 | MDSM | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Oct 9, 2008 | NWAP | NEW APPLICATION ENTERED | — |